Abstract
Diabetes mellitus is a widespread endocrine disease worldwide, accompanying chronic hyperglycemia. In this study, we investigated the effect of hydroxytyrosol, which exerts an antioxidant effect, on the expressions of insulin and peroxiredoxin-6 (Prdx6), which protect cells against oxidative injury in diabetic rat pancreas. This experimental study had four groups with ten animals in each group: control (nondiabetic) group, hydroxytyrosol group [10 mg/kg/day intraperitoneal injection (ip) hydroxytyrosol for 30 days], streptozotocin group (single ip injection of 55 mg/kg streptozotocin), and streptozotocin + hydroxytyrosol group (single ip injection of streptozotocin and ip injection of 10 mg/kg/day hydroxytyrosol for 30 days). During the experiment, blood glucose levels were measured at regular intervals. Insulin expression was determined by immunohistochemistry and Prdx6 expression was determined by immunohistochemistry and western blot. Immunohistochemistry and western blot results were analyzed by one-way ANOVA with applied Holm–Sidak multiple comparison test, and blood glucose results were analyzed by two-way repeated measures ANOVA with applied Tukey’s multiple comparison test. Blood glucose levels on days 21 and 28 were significantly lower in the streptozotocin + hydroxytyrosol group compared with the streptozotocin group (day 21, p = 0.049 and day 28, p = 0.003). Expression of both insulin and Prdx6 were lower in the streptozotocin and the streptozotocin + hydroxytyrosol groups compared with the control and hydroxytyrosol groups (p < 0.001). Insulin and Prdx6 expression in the streptozotocin + hydroxytyrosol group were higher compared with the streptozotocin group (p < 0.001). The immunohistochemical findings of Prdx6 and western blot were the same. In conclusion, hydroxytyrosol, which is an antioxidant compound, increased Prdx6 and insulin expression in diabetic rats. Insulin increased by hydroxytyrosol may have been effective in reducing blood glucose levels. Furthermore, hydroxytyrosol may exert its effect on insulin by increasing Prdx6 expression. Thus, hydroxytyrosol may decrease or prevent several hyperglycemia-dependent complications by increasing the expression of these proteins.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amirshahrokhi K, Zohouri A (2021) Carvedilol prevents pancreatic beta-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-kappaB, COX-2, iNOS and oxidative stress. Cytokine 138:155394. https://doi.org/10.1016/j.cyto.2020.155394
Aunon-Calles D, Canut L, Visioli F (2013) Toxicological evaluation of pure hydroxytyrosol. Food Chem Toxicol 55:498–504. https://doi.org/10.1016/j.fct.2013.01.030
Bertelli M, Kiani AK, Paolacci S, Manara E, Kurti D, Dhuli K, Bushati V, Miertus J, Pangallo D, Baglivo M, Beccari T, Michelini S (2020) Hydroxytyrosol: a natural compound with promising pharmacological activities. J Biotechnol 309:29–33. https://doi.org/10.1016/j.jbiotec.2019.12.016
da Rocha FJ, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, Cavan D, Makaroff LE (2016) IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117:48–54. https://doi.org/10.1016/j.diabres.2016.04.016
Damond N, Engler S, Zanotelli VRT, Schapiro D, Wasserfall CH, Kusmartseva I, Nick HS, Thorel F, Herrera PL, Atkinson MA, Bodenmiller B (2019) A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab 29(3):755-768e755. https://doi.org/10.1016/j.cmet.2018.11.014
Fisher AB (2011) Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid Redox Signal 15(3):831–844. https://doi.org/10.1089/ars.2010.3412
Hamden K, Allouche N, Damak M, Elfeki A (2009) Hypoglycemic and antioxidant effects of phenolic extracts and purified hydroxytyrosol from olive mill waste in vitro and in rats. Chem Biol Interact 180(3):421–432. https://doi.org/10.1016/j.cbi.2009.04.002
Hu T, He XW, Jiang JG, Xu XL (2014) Hydroxytyrosol and its potential therapeutic effects. J Agric Food Chem 62(7):1449–1455. https://doi.org/10.1021/jf405820v
Immenschuh S, Baumgart-Vogt E (2005) Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7(5–6):768–777. https://doi.org/10.1089/ars.2005.7.768
Katsarou A, Gudbjornsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark A (2017) Type 1 diabetes mellitus. Nat Rev Dis Primers 3:17016. https://doi.org/10.1038/nrdp.2017.16
Kolb H (1987) Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab Rev 3(3):751–778. https://doi.org/10.1002/dmr.5610030308
Las G, Oliveira MF, Shirihai OS (2020) Emerging roles of beta-cell mitochondria in type-2-diabetes. Mol Aspects Med 71:100843. https://doi.org/10.1016/j.mam.2019.100843
Leger CL, Carbonneau MA, Michel F, Mas E, Monnier L, Cristol JP, Descomps B (2005) A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. Eur J Clin Nutr 59(5):727–730. https://doi.org/10.1038/sj.ejcn.1602133
Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51(2):216–226. https://doi.org/10.1007/s00125-007-0886-7
Lopez-Villodres JA, Abdel-Karim M, De La Cruz JP, Rodriguez-Perez MD, Reyes JJ, Guzman-Moscoso R, Rodriguez-Gutierrez G, Fernandez-Bolanos J, Gonzalez-Correa JA (2016) Effects of hydroxytyrosol on cardiovascular biomarkers in experimental diabetes mellitus. J Nutr Biochem 37:94–100. https://doi.org/10.1016/j.jnutbio.2016.07.015
Lytrivi M, Castell AL, Poitout V, Cnop M (2020) Recent insights into mechanisms of beta-cell lipo- and glucolipotoxicity in type 2 diabetes. J Mol Biol 432(5):1514–1534. https://doi.org/10.1016/j.jmb.2019.09.016
Marrano N, Spagnuolo R, Biondi G, Cignarelli A, Perrini S, Vincenti L, Laviola L, Giorgino F, Natalicchio A (2021) Effects of extra virgin olive oil polyphenols on beta-cell function and survival. Plants (Basel). https://doi.org/10.3390/plants10020286
Novoselova EG, Glushkova OV, Parfenuyk SB, Khrenov MO, Lunin SM, Novoselova TV, Sharapov MG, Shaev IA, Novoselov VI (2019) Protective effect of peroxiredoxin 6 against toxic effects of glucose and cytokines in pancreatic RIN-m5F beta-cells. Biochemistry (mosc) 84(6):637–643. https://doi.org/10.1134/S0006297919060063
Novoselova EG, Glushkova OV, Khrenov MO, Parfenyuk SB, Lunin SM, Novoselova TV, Fesenko EE (2020a) Participation of Hsp70 and Hsp90alpha heat shock proteins in stress response in the course of type 1 diabetes mellitus. Dokl Biol Sci 493(1):124–127. https://doi.org/10.1134/S0012496620040079
Novoselova EG, Glushkova OV, Lunin SM, Khrenov MO, Parfenyuk SB, Novoselova TV, Sharapov MG, Novoselov VI, Fesenko EE (2020b) Peroxiredoxin 6 attenuates alloxan-induced type 1 diabetes mellitus in mice and cytokine-induced cytotoxicity in RIN-m5F beta cells. J Diabetes Res 2020:7523892. https://doi.org/10.1155/2020/7523892
Pacifici F, Della-Morte D, Capuani B, Coppola A, Scioli MG, Donadel G, Andreadi A, Ciccosanti F, Fimia GM, Bellia A, Orlandi A, Lauro D (2022) Peroxiredoxin 6 modulates insulin secretion and beta cell death via a mitochondrial dynamic network. Front Endocrinol (Lausanne) 13:842575. https://doi.org/10.3389/fendo.2022.842575
Paula FM, Ferreira SM, Boschero AC, Souza KL (2013) Modulation of the peroxiredoxin system by cytokines in insulin-producing RINm5F cells: down-regulation of PRDX6 increases susceptibility of beta cells to oxidative stress. Mol Cell Endocrinol 374(1–2):56–64. https://doi.org/10.1016/j.mce.2013.04.009
Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50(5):567–575. https://doi.org/10.1016/j.freeradbiomed.2010.12.006
Ristagno G, Fumagalli F, Porretta-Serapiglia C, Orru A, Cassina C, Pesaresi M, Masson S, Villanova L, Merendino A, Villanova A, Cervo L, Lauria G, Latini R, Bianchi R (2012) Hydroxytyrosol attenuates peripheral neuropathy in streptozotocin-induced diabetes in rats. J Agric Food Chem 60(23):5859–5865. https://doi.org/10.1021/jf2049323
Roma LP, Jonas JC (2020) Nutrient metabolism, subcellular redox state, and oxidative stress in pancreatic islets and beta-cells. J Mol Biol 432(5):1461–1493. https://doi.org/10.1016/j.jmb.2019.10.012
Rossini AA, Like AA, Dulin WE, Cahill GF Jr (1977) Pancreatic beta cell toxicity by streptozotocin anomers. Diabetes 26(12):1120–1124. https://doi.org/10.2337/diab.26.12.1120
Soylu H, Acar N, Ozbey O, Unal B, Koksal IT, Bassorgun I, Ciftcioglu A, Ustunel I (2016) Characterization of notch signalling pathway members in normal prostate, prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma. Pathol Oncol Res 22(1):87–94. https://doi.org/10.1007/s12253-015-9983-y
Soylu H, Kirca M, Avci S, Ozpolat B, Ustunel I (2021) Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells. Exp Mol Pathol 119:104607. https://doi.org/10.1016/j.yexmp.2021.104607
Strandell E, Eizirik DL, Korsgren O, Sandler S (1988) Functional characteristics of cultured mouse pancreatic islets following exposure to different streptozotocin concentrations. Mol Cell Endocrinol 59(1–2):83–91. https://doi.org/10.1016/0303-7207(88)90198-0
Sun P, Huang R, Qin Z, Liu F (2022) Influence of tangeretin on the exponential regression of inflammation and oxidative stress in streptozotocin-induced diabetic nephropathy. Appl Biochem Biotechnol 194(9):3914–3929. https://doi.org/10.1007/s12010-022-03920-w
Tatipamula VB, Kolli MK, Lagu SB, Paidi KR, P RR, Yejella RP (2019) Novel indolizine derivatives lowers blood glucose levels in streptozotocin-induced diabetic rats: a histopathological approach. Pharmacol Rep 71 (2):233-242. https://doi.org/10.1016/j.pharep.2018.11.004
Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46(11):1733–1742. https://doi.org/10.2337/diab.46.11.1733
Tuttle KR (2021) Breaking new ground with incretin therapy in diabetes. N Engl J Med 385(6):560–561. https://doi.org/10.1056/NEJMe2109957
Wang N, Liu Y, Ma Y, Wen D (2018) Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice. J Nutr Biochem 57:180–188. https://doi.org/10.1016/j.jnutbio.2018.03.018
Zhang S, Ma X, Zhang L, Sun H, Liu X (2017) Capsaicin reduces blood glucose by increasing insulin levels and glycogen content better than capsiate in streptozotocin-induced diabetic rats. J Agric Food Chem 65(11):2323–2330. https://doi.org/10.1021/acs.jafc.7b00132
Zhang YJ, Chen X, Zhang L, Li J, Li SB, Zhang X, Qin L, Sun FR, Li DQ, Ding GZ (2019) Protective effects of 3,4-dihydroxyphenylethanol on spinal cord injury-induced oxidative stress and inflammation. NeuroReport 30(15):1016–1024. https://doi.org/10.1097/WNR.0000000000001318
Acknowledgements
We would like to thank Eda Nur Almali, Nagehan Ulas, and Nur Hilal Elciyar for their technical support. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare that they have no financial interest.
Author information
Authors and Affiliations
Contributions
HS: conceptualization, methodology, data curation, formal analysis, investigation, validation, visualization, writing—original draft preparation, writing—reviewing and editing, supervision. KK: methodology, investigation, validation, visualization, writing—original draft preparation.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Soylu, H., Karacor, K. The effects of hydroxytyrosol on Prdx6 and insulin expression in diabetic rat pancreases. Histochem Cell Biol 160, 127–134 (2023). https://doi.org/10.1007/s00418-023-02207-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-023-02207-3